GI Innovation allergic diseases treatment
Scope
Date
~
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
ST Pharm exports $14.6 mn worth of drug ingredients to Europe
ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem completes acquisition of US biotech firm AVEO
LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Sanfilippo treatment eligible for FDA priority review
GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...
Jan 18, 2023 (Gmt+09:00)
-
Electronics
Samsung to open Galaxy Experience Spaces for Galaxy Unpacked
Samsung Electronics Co. will open 29 interactive Galaxy Experience Spaces in 24 locations in 19 countries, following the Galaxy Unpacked event to be...
Jan 18, 2023 (Gmt+09:00)
-
Future mobility
SK Innovation-invested Amogy tests ammonia-powered heavy truck
Amogy Inc. has successfully tested its ammonia-hydrogen power system for large-size semi trucks – the first time that ammonia has been used as...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
MedPacto's anti-cancer substance designated as US FDA fast-track item
South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...
Jan 18, 2023 (Gmt+09:00)
-
Cloud computing
Bespin Global establishes Vietnam Tech Center for cloud, digital innovation
South Korea's cloud management company Bespin Global will foster cloud and digital innovation industries in Central Vietnam. To this end, the compan...
Jan 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for EMA approval of smaller dose formulation of Yuflyma
Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals launches uremia itching treatment tablet
SK Chemicals said on Monday that it has launched Remitch in orally disintegrating tablets, a treatment for intractable uremic pruritus (uremia itchi...
Jan 16, 2023 (Gmt+09:00)
-
Perspectives
Elon Musk’s vision for Korean innovation isn’t crazy
For a “genius,” Elon Musk sure does say lots of mindless things. Yet on any list of the least crazy ideas from the Tesla founder, his take...
Jan 15, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Biomedics gets approval for Parkinson's disease clinical trials
South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...
Jan 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N gets approval to sell K-CAB in Singapore
South Korean biohealth company HK inno.N said on Wednesday that it has received an item approval for K-CAB, a new drug for gastroesophageal reflux d...
Jan 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma attains patent for solid cancer treatment antibody
Prestige Biopharma Korea said on Tuesday that it has obtained a domestic patent for the CTHRC1 neutralizing antibody of the drug candidate PBP1710. ...
Jan 12, 2023 (Gmt+09:00)
-
Korean Innovators at CES 2023
SK Ecoplant looks to enter US battery recycling business: CEO
SK Ecoplant Co., a South Korean construction engineering company, will enter the US battery recycling business by investing in promising startups, C...
Jan 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments
Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...
Jan 05, 2023 (Gmt+09:00)
-
Korean Innovators at CES 2023
Hyundai Motor Group to make debuts of innovative startups at CES
Hyundai Motor Group's open innovation platform Zero1ne will showcase innovative technologies from ten South Korean startups at CES 2023, the world's...
Jan 05, 2023 (Gmt+09:00)
-
Korean Innovators at CES 2023
Korean startups win 4 out of 23 Best of Innovations at CES 2023
LAS VEGAS – South Korean startups have won four out of the 23 Best of Innovation awards from Consumer Technology Association (CTA), which host...
Jan 04, 2023 (Gmt+09:00)
-
Bio & Pharma
NeoImmuneTech, US think tank to develop treatment for acute radiation syndrome
Biopharmaceutical company NeoImmuneTech has grabbed an opportunity to supply new drug candidates in development as strategic items to the US gover...
Jan 04, 2023 (Gmt+09:00)
-
Korean Innovators at CES 2023
Seoul Viosys receives CES Display Innovation Award
Seoul Viosys Co. said on Tuesday that it received the Innovation Award in the display category for a component called "WICOP pixel" at CES 2023, the...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Remsima receives approval in 100 countries in 10 years
South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals introduces Tiglutik, treatment for Lou Gehrig's disease
SK Chemicals said on Monday that it is strengthening its portfolio of neurological diseases by introducing Tiglutik (riluzole), Lou Gehrig's disease...
Jan 02, 2023 (Gmt+09:00)
-
Electronics
Korean firms head to CES 2023 to showcase innovative technologies
LAS VEGAS, NV – A growing number of South Korea’s leading companies and startups are heading to CES 2023, the world’s largest tech...
Jan 02, 2023 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Economy
Italian envoy to Korea says what works in Korea works globally
Italian Ambassador to South Korea Federico Failla said that as both Italy and Korea cherish and prioritize the importance of tradition and innovatio...
Dec 26, 2022 (Gmt+09:00)
-
Leadership & Management
Hyundai Heavy Industries Group changes its name to HD Hyundai
HD Hyundai held a 50th-anniversary vision declaration ceremony at its Global R&D Center in Seongnam, Gyeonggi Province, on Monday where it annou...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Fintech
South Korea doubles gov't fintech innovation fund to $781 million
The South Korean government will double the value of its Fintech Innovation Fund, a source of financial support for the financial technology or fint...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
CENYX Biotech, developing treatment for brain damage with ROS-scavenging, nano-sized heavy metals
When severe brain diseases such as cerebral infarction or cerebral hemorrhage occur, the blood-brain barrier (BBB) in our body no longer functions p...
Dec 26, 2022 (Gmt+09:00)